Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
Europe
No access to market insights

The growing population of elderly women is one of the key factors anticipated to increase the prevalence of women’s health issues in Europe. According to Eurostat, approximately 43% of European women are aged above 65.

Various initiatives undertaken by government agencies and NGOs, such as the European Institute of Women’s Health (EIWH) and Women’s Health Organization, to raise awareness about women’s health are anticipated to positively impact the market.

The increasing number of market players involved in manufacturing women's health products in European countries and the growing prevalence of various women’s health issues, such as postmenopausal symptoms, PCOS, & infertility, are anticipated to boost the market. The EMA evaluates the application for human use.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Scope

Women's health market segmentation & scope
Application
Hormonal Infertility
Contraceptives
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Polycystic Ovary Syndrome (PCOS)
Drug Class
Hormonal Therapies
Bone Health Agents
Fertility Agents
GnRH Modulators
Pain and Symptom Management
Metabolic Agents
Others
Age
50 years and above
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Others
Others

Women's Health Market Companies

Name Profile # Employees HQ Website

Europe Women's Health Market Outlook Share, 2024 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more